Assessment of preclinical target organ damage in hypertesion: left ventricular hypertrophy.
Rosei
E Agabiti
EA
D000959:Antihypertensive Agents / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000209:etiology* / Q000503:physiopathology; D011237:Predictive Value of Tests; D011379:Prognosis; D018487:Ventricular Dysfunction, Left / Q000209:etiology / Q000517:prevention & control*; D016277:Ventricular Function, Left / Q000187:drug effects; D014944:World Health Organization
D000959:Antihypertensive Agents